Dmitri Talantov
Johnson & Johnson (United States) · 28 works · 4,993 citations · h-index 12
Top works
- Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
- Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
- Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
- Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
- Quantitative Gene Expression Profiling in Formalin-Fixed, Paraffin-Embedded Tissues Using Universal Bead Arrays
- Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
- A Quantitative Reverse Transcriptase-Polymerase Chain Reaction Assay to Identify Metastatic Carcinoma Tissue of Origin
- Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer
- Robust multi-tissue gene panel for cancer detection
- Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical Prostatectomy
- The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy.
- Gene profiling of tumor tissue in the diagnosis of patients with carcinoma of unknown primary site (CUP): Evaluation of the Veridex 10-gene molecular assay
- Multi-center validation of the 76-gene prognostic signature in lymph node negative (LNN) primary breast cancer
- Feasibility of wearable sensor signals and self-reported symptoms to prompt at-home testing for acute respiratory viruses in the USA (DETECT-AHEAD): a decentralised, randomised controlled trial
- A quantitative reverse transcriptase polymerase chain reaction assay to identify metastatic carcinoma tissue of origin
- Gene expression profiling to predict recurrent Dukes' B colon cancer
- Development of a clinically feasible molecular assay to predict recurrence of Dukes’ B colon cancer
- State-of-the-Art Lecture: A gene expression signature to predict recurrence of Dukes’ B colon cancer
- Supplementary Data, Figure S1 and Table S1 from Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions